What are you looking for?

How to Switch from a Probabilistic to a Deterministic Approach for Your Container Closure Integrity Testing


Over the past two decades, industries have seen a huge number of regulatory changes. These can be found in: 

  • FDA Guidelines for Industry (2008), which replaced sterility testing with container closure integrity testing (CCIT) 
  • USP Chapter (2019), which details the processes companies should follow when carrying out packaging integrity assessments for sterile products 
  • EMA Annex 1 (2020), which outlines the appropriate manufacturing process for sterile medical products 

With these changes in mind, companies need to start using  a deterministic approach for any new pharmaceutical product or medical device they take to market. 

This new deterministic approach is more sensitive, more accurate and more non-restrictive, and helps ensure more reliable results during stability studies. 


Daniel Tatarsky will moderate a  discussion, with our panel of experts, on how clients can easily switch from a probabilistic to a deterministic approach. The panel will then review the different options for implementing a deterministic container closure integrity testing (CCIT) strategy based on regulatory guidelines – with a focus on vacuum, helium, and high voltage – and discuss how to choose the best methods. 


  • Introduction 
  • Compare probabilistic and deterministic approaches 
  • Review the different methods CCIT and its applications 
  • Q&A 


Target Audience: The webinar is aimed at all quality control and quality assurance managers, as well as packaging project managers in the pharma, biopharma and medical devices industry. 

Language: English 

Can't make a live session? Register now and receive a complimentary recording after the live event.

Related Webinars

News & Insights

  • SGS-CSTC Standards Technical Services Co., Ltd. Beijing Head Office

A-16/F Century Yuhui Mansion,

No.73 Fucheng Road, Haidian District, 100142,

Beijing, Beijing Municipality, China